cataract surgery is extremely popular. almost everyone I known over 70 has had it or is going to get it soon. that is a growing demographic for sure.
Revenues driven by recent contracts for the most advanced life saving diagnostics will expand 150 times in the next 24 months. And that is just the beginning!
Millennium Healthcare (MHCC) recently announced newly SIGNED contracts with ACO’s IPA’s and MSO’s to provide exclusive, state-of-the-art, non-invasive cardiovascular and cancer diagnostics to 1,300 locations that will escalate Millennium’s current revenues of $2 million per year to over $300 million per year.
Cardiovascular and cancer diagnostics rolling out to physician’s offices this year.
Revenues will begin rapid growth by year end.
Market size for Millennium Diagnostics is 35,000 primary care offices. The first 1,300 recently contracted with Millennium and the rest are standing in line to sign up with Millennium because:
§ Millenniums program increases physician’s revenues dramatically
§ Millennium’s diagnostics are fully paid by Medicare and are free to patients
§ Millennium’s diagnostics appeal to patients because they are life-saving, fast, painless and highly accurate
§ Millennium’s diagnostics are exclusive from Millennium only
§ The physician pays no up front capital costs
Millennium’s market cap is under $40 million today and shares are selling at under $1.00.
What will this growth do to the price of MHCC shares?
Millennium HealthCare is well positioned for explosive growth that is rarely seen.
Sentiment: Strong Buy
Get IN now before they announce European approval of Omidria. Get IN now before they announce a distribution aggreement with European partner/distributor ............... but most of all get in now because $21 is more than feasible when they start selling this must have product.
What you should be teeling people is buy more as it approaches $12 ............ but that's too much like good advice.
Omer has all the right products on pipe line plus an FDA approved product that has no competition. OMETRIA will replace existing mixing of two products by Ophalmologists in a year or so.. The FDA will not allow the mixing if there is a product off the selve to be used, Watch and learn from someone with twenty years of experiance in this sector.
Be patient. Gas has run out. No near term news on the horizon to reestablish uptrend. Chronic selling will try to beg for a reasonable bid price. I say $12 but more likely $9 when you consider the overbought market and maxed out market.
This is my favorite. May 19th he said we are headed to 9 and within a month shot to 18+. Can you make a worse market call than that? I don't think you could get it this wrong if you tried.
I notice he only uses this ID for OMER. His short is WAY underwater at this point. He may be that phonymd in disguise. There can't be 2 people that bad at investing on one board.
LOL --- tiny is back!! You knew the coward would come out of hiding. Only up 70% since his last post now! This guy is the poster child for the term LOSER.